FDA
-
-
-
-
-
-
-
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
-
-
-
-
-
-
-
Vericel Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Vericel Corporation (VCEL)
-
-
-
-
-
-
-
Vericel (VCEL) Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
-
-
-
-
-
-
-
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
-
-
-
-
-
-
-
MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
-
329,911 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

